159 related articles for article (PubMed ID: 10023311)
1. Stage-specific treatment costs for cervical cancer in the United Kingdom.
Wolstenholme JL; Whynes DK
Eur J Cancer; 1998 Nov; 34(12):1889-93. PubMed ID: 10023311
[TBL] [Abstract][Full Text] [Related]
2. Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UK.
Brown RE; Breugelmans JG; Theodoratou D; Bénard S
Curr Med Res Opin; 2006 Apr; 22(4):663-70. PubMed ID: 16684427
[TBL] [Abstract][Full Text] [Related]
3. Costs of cervical cancer and precancerous lesions treatment in a publicly financed health care system.
Tang CH; Pwu RF; Tsai IC; Wang HI; You SL; Chen CA; Scuffham PA; Hsieh CY; Chou CY; Lin SR; Chen YD; Chen CJ
Arch Gynecol Obstet; 2010 Apr; 281(4):683-95. PubMed ID: 19730873
[TBL] [Abstract][Full Text] [Related]
4. Cost of cervical cancer treatment: implications for providing coverage to low-income women under the Medicaid expansion for cancer care.
Subramanian S; Trogdon J; Ekwueme DU; Gardner JG; Whitmire JT; Rao C
Womens Health Issues; 2010; 20(6):400-5. PubMed ID: 21050999
[TBL] [Abstract][Full Text] [Related]
5. The management of cervical intra-epithelial neoplasia (CIN): extensiveness and costs in The Netherlands.
van Ballegooijen M; Koopmanschap MA; Habbema JD
Eur J Cancer; 1995 Sep; 31A(10):1672-6. PubMed ID: 7488423
[TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness of high-risk HPV DNA testing for cervical cancer screening in South Africa.
Vijayaraghavan A; Efrusy M; Lindeque G; Dreyer G; Santas C
Gynecol Oncol; 2009 Feb; 112(2):377-83. PubMed ID: 19081611
[TBL] [Abstract][Full Text] [Related]
7. Cryotherapy in the management of cervical intraepithelial neoplasia in developing countries.
Adewole IF; Babarinsa IA; Odeniyi GD
Int J Gynaecol Obstet; 1998 Jan; 60(1):69-70. PubMed ID: 9506421
[No Abstract] [Full Text] [Related]
8. Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination.
Östensson E; Fröberg M; Leval A; Hellström AC; Bäcklund M; Zethraeus N; Andersson S
PLoS One; 2015; 10(9):e0139062. PubMed ID: 26398189
[TBL] [Abstract][Full Text] [Related]
9. The Direct Medical Costs of Diseases Associated with Human Papillomavirus Infection in Manitoba, Canada.
Righolt CH; Pabla G; Mahmud SM
Appl Health Econ Health Policy; 2018 Apr; 16(2):195-205. PubMed ID: 29299769
[TBL] [Abstract][Full Text] [Related]
10. Reimbursed Costs of Management of Uterine Cervical Lesions in Poland--a Descriptive Analysis of Data from the National Health Fund and the Ministry of Health.
Nowakowski A; Śliwczyński A; Seroczyński P; Cybulski M; Teter Z
Cent Eur J Public Health; 2016 Jun; 24(2):163-8. PubMed ID: 27178030
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy.
Giorgi Rossi P; Ricciardi A; Cohet C; Palazzo F; Furnari G; Valle S; Largeron N; Federici A
BMC Public Health; 2009 Feb; 9():71. PubMed ID: 19243586
[TBL] [Abstract][Full Text] [Related]
12. Re: An alternative cost-effectiveness analysis of ThinPrep in the Australian setting.
Llewellyn H
Aust N Z J Obstet Gynaecol; 2006 Feb; 46(1):67. PubMed ID: 16441702
[No Abstract] [Full Text] [Related]
13. Incidence and costs of cervical intraepithelial neoplasia in the Korean population.
Chang HK; Seo SS; Myong JP; Yu YL; Byun SW
J Gynecol Oncol; 2019 May; 30(3):e37. PubMed ID: 30887758
[TBL] [Abstract][Full Text] [Related]
14. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study.
TOMBOLA Group
BMJ; 2009 Jul; 339():b2549. PubMed ID: 19638648
[TBL] [Abstract][Full Text] [Related]
15. Immediate colposcopy or cytological surveillance for women with mild dyskaryosis: a cost effectiveness analysis.
Flannelly G; Campbell MK; Meldrum P; Torgerson DJ; Templeton A; Kitchener HC
J Public Health Med; 1997 Dec; 19(4):419-23. PubMed ID: 9467148
[TBL] [Abstract][Full Text] [Related]
16. [Estimated cost of managing invasive cervical cancer in Tunisia].
Ben Gobrane H; Aounallah-Skhiri H; Oueslati F; Frikha H; Achour N; Hsairi M
Sante Publique; 2009; 21(6):561-9. PubMed ID: 20429226
[TBL] [Abstract][Full Text] [Related]
17. Management of precancerous cervical lesions in iran: a cost minimizing study.
Nahvijou A; Sari AA; Zendehdel K; Marnani AB
Asian Pac J Cancer Prev; 2014; 15(19):8209-13. PubMed ID: 25339007
[TBL] [Abstract][Full Text] [Related]
18. The price of guidelines: revising the national guidelines for managing Australian women with abnormal pap smears.
Mitchell H
Sex Health; 2006 Mar; 3(1):53-5. PubMed ID: 16607975
[TBL] [Abstract][Full Text] [Related]
19. Economic burden associated with the management of cervical cancer, cervical dysplasia and genital warts in Belgium.
Annemans L; Rémy V; Lamure E; Spaepen E; Lamotte M; Muchada JP; Largeron N
J Med Econ; 2008; 11(1):135-50. PubMed ID: 19450115
[TBL] [Abstract][Full Text] [Related]
20. Cervical neoplasia.
Govindappagari S; Schiavone MB; Wright JD
Clin Obstet Gynecol; 2011 Dec; 54(4):528-36. PubMed ID: 22031243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
